XML 19 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Gross sales $ 13,131,946 $ 10,412,491
Allowances (803,643) (264,255)
Total net sales 12,328,303 10,148,236
Costs of sales 3,430,274 3,700,537
Gross profit 8,898,028 6,447,699
Operating expenses 10,657,973 12,560,297
(Loss) from operations (1,759,945) (6,112,598)
Realized and unrealized gain (loss) on marketable securities 542,710 (62,010)
(Increase) decrease of contingent liability (8,500,000) 16,898,006
Interest (expense) income (10,386) 7,267
Income (loss) before provision for income taxes (9,727,621) 10,730,665
Benefit for income taxes 332,000 2,240,300
Net (loss) income from continuing operations (9,395,621) 12,970,965
Net (loss) income from discontinued operations, net of tax (Note 14) 0 (41,202)
Net (loss) income (9,395,621) 12,929,763
Preferred dividends 100,050 66,734
Net (loss) income attributable to cbdMD, Inc. common shareholders $ (9,495,671) $ 12,863,029
Net (loss) income per share:    
Basic earnings per share $ (0.18) $ 0.46
Diluted earnings per share $ (.18) $ .45
Weighted average number of shares - basic 52,130,870 27,720,356
Weighted average number of shares - diluted 52,130,870 28,553,856